A Trial of PX-12 in Patients With a Histologically or Cytologically Confirmed Diagnosis of Advanced or Metastatic Cancer
Clinical trial NCT00736372 · COMPLETED
Trial details
- NCT number
- NCT00736372
- Sponsor
- Cascadian Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2009-08-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.